Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 307094, 7 pages
http://dx.doi.org/10.1155/2015/307094
Research Article

Antileukemic Effect of Tualang Honey on Acute and Chronic Leukemia Cell Lines

1Department of Hematology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
2Department of Medicine, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia
3Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia

Received 27 July 2015; Revised 5 October 2015; Accepted 7 October 2015

Academic Editor: Massimo Breccia

Copyright © 2015 Nik Muhd Khuzaimi Nik Man et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Lim, H. Yahaya, and T. Lim, The First Report of the National Cancer Registry Cancer Incidence in Malaysia, Ministry of Health, Kuala Lumpur, Malaysia, 2003.
  2. C. M. Lucas, L. Wang, G. M. Austin et al., “A population study of imatinib in chronic myeloid leukaemia demonstrates lower efficacy than in clinical trials,” Leukemia, vol. 22, no. 10, pp. 1963–1966, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Mohamed, K. N. S. Sirajudeen, M. Swamy, N. S. Yaacob, and S. A. Sulaiman, “Studies on the antioxidant properties of Tualang honey of Malaysia,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 7, no. 1, pp. 59–63, 2010. View at Google Scholar · View at Scopus
  4. R. K. Kishore, A. S. Halim, M. S. N. Syazana, and K. N. S. Sirajudeen, “Tualang honey has higher phenolic content and greater radical scavenging activity compared with other honey sources,” Nutrition Research, vol. 31, no. 4, pp. 322–325, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. C. S. Bestwick and L. Milne, “Influence of galangin on HL-60 cell proliferation and survival,” Cancer Letters, vol. 243, no. 1, pp. 80–89, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. C. S. Bestwick, L. Milne, and S. J. Duthie, “Kaempferol induced inhibition of HL-60 cell growth results from a heterogeneous response, dominated by cell cycle alterations,” Chemico-Biological Interactions, vol. 170, no. 2, pp. 76–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Akan and A. Garip, “Protective role of quercetin: antioxidants may protect cancer cells from apoptosis and enhance cell durability,” WebmedCentral, vol. 2, no. 1, Article ID WMC001504, 2011. View at Publisher · View at Google Scholar
  8. M. I. Khalil, N. Alam, M. Moniruzzaman, S. A. Sulaiman, and S. H. Gan, “Phenolic acid composition and antioxidant properties of Malaysian honeys,” Journal of Food Science, vol. 76, no. 6, pp. C921–C928, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Ahmed and N. H. Othman, “Review of the medicinal effects of tualang honey and a comparison with Manuka honey,” Malaysian Journal of Medical Sciences, vol. 20, no. 3, pp. 6–13, 2013. View at Google Scholar · View at Scopus
  10. E. Angst, J. L. Park, A. Moro et al., “The flavonoid quercetin inhibits pancreatic cancer growth in vitro and in vivo,” Pancreas, vol. 42, no. 2, pp. 223–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Duo, G.-G. Ying, G.-W. Wang, and L. Zhang, “Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation,” Molecular Medicine Reports, vol. 5, no. 6, pp. 1453–1456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Tallman, D. G. Gilliland, and J. M. Rowe, “Drug therapy for acute myeloid leukemia,” Blood, vol. 106, no. 4, pp. 1154–1163, 2005. View at Publisher · View at Google Scholar · View at Scopus